Effects of Di(2-ethylhexyl) phthalate (DEHP) on female fertility and adipogenesis in C3H/N Mice

Environmental Health Perspectives

Volumn 120, Issue 8, 2012, Pages 1123-1129

  Schmidt, Juliane Susanne ^a   Schaedlich, Kristina ^a   Fiandanese, Nadia ^b   Pocar, Paola ^b   Fischer, Bernd ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Adiponectin; Adipose tissue; DEHP; Endocrine disruptors; Female reproduction; Leptin; Obesity; Phthalates

Indexed keywords

ADIPONECTIN; FATTY ACID BINDING PROTEIN 4; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHTHALIC ACID BIS (2 ETHYLHEXYL) ESTER; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FEMALE FERTILITY; FOOD INTAKE; HISTOLOGY; INTRAABDOMINAL FAT; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUS ABORTION; WEIGHT GAIN;

ADIPOGENESIS; ANIMALS; BASE SEQUENCE; BODY WEIGHT; DIETHYLHEXYL PHTHALATE; DNA PRIMERS; FEEDING BEHAVIOR; FEMALE; FERTILITY; MICE; MICE, INBRED C3H; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION;

MUS;

EID: 84864740299     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104016     Document Type: Article

References (45)

1. Adibi JJ, Perera FP, Jedrychowski W, Camann DE, Barr D, Jacek R, et al. 2003. Prenatal exposures to phthalates among women in New York City and Krakow, Poland. Environ Health Perspect 111:1719-1722.
2. Adibi JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, Herrick R, et al. 2008. Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect 116:467-473.
3. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269(5223):546-549.
4. Carr MC, Brunzell JD. 2004. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 89(6):2601-2607.
5. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1):156-159.
6. Davis BJ, Maronpot RR, Heindel JJ. 1994. Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol Appl Pharmacol 128(2):216-223.
7. European Union. 2005. Directive 2005/84/EC of the European Parliament and of the Council. Available: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2005:344:0040:0043:en:PDF [accessed 24 June 2012].
8. European Union. 2008. European Union Risk Assessment Report. Bis(2-ethylhexyl)phthalate (DEHP). Available: http://www.dehp-facts.com/upload/documents/webpage/DEHP%20RA%20report%20full.pdf [accessed 24 June 2012].
9. Feige JN, Gelman L, Rossi D, Zoete V, Métivier R, Tudor C, et al. 2007. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor γ modulator that promotes adipogenesis. J Biol Chem 282(26):19152-19166.
10. Feige JN, Gerber A, Casals-Casas C, Yang Q, Winkler C, Bedu E, et al. 2010. The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARα-dependent mechanisms. Environ Health Perspect 118:234-241.
11. Fowler PA, Bellingham M, Sinclair KD, Evans NP, Pocar P, Fischer B, et al. 2012. Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. Mol Cell Endocrinol 355(2):231-239.
12. Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS.1995. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 12:1311-1314.
13. Frederiksen H, Skakkebæk NE, Andersson AM. 2007. Metabolism of phthalates in humans. Mol Nutr Food Res 51:899-911.
14. Grande SW, Andrade AJM, Talsness CE, Grote K, Chahoud I. 2006. A dose-response study following in utero and lactational exposure to di(2 ethylhexyl)phthalate: effects on female rat reproductive development. Toxicol Sci 91(1):247-254.
15. Grün F, Blumberg B. 2009. Endocrine disrupters as obesogens. Mol Cell Endocrinol. 304(1-2):19-29.
16. Hatch EE, Nelson JW, Qureshi MM, Weinberg J, Moore LL, Singer M, et al. 2008. Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 7:27; doi:10.1186/1476-069X-7-27 [Online 3 June 2008].
17. Hauser R, Calafat AM. 2005. Phthalates and human health. Occup Environ Med 2(11):806-818.
18. Hauser R, Meeker JD, Singh NP, Silva MJ, Ryan L, Duty S, et al. 2007. DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites. Hum Reprod 22(3):688-695.
19. Heindel JJ, vom Saal FS. 2009. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol 304(1-2):90-96.
20. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, et al. 2006. Adiponectin and adiponectin receptors in insulin resistance, diabetes and metabolic syndrom. J Clin Invest 116:1784-1792.
21. Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, et al. 2002. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. Reprod Toxicol 16:529-653.
22. Kluwe WM, McConnell EE, Huff JE, Haseman JK, Douglas JF, Hartwell WV. 1982. Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute. Environ Health Perspect 45:129-133.
23. Lamb JC IV, Chapin RE, Teague J, Lawton AD, Reel JR. 1987. Reproductive effects of four phthalic acid esters in the mouse. Toxicol Appl Pharmacol 88(2):255-269.
24. Lapinskas PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, et al. 2005. Role of PPARα in mediating the effects of phthalates and metabolites in the liver. Toxicology 207(1):149-163.
25. Latini G, de Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, et al. 2003. In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environ Health Perspect 111:1783-1785.
26. Latini G, Gallo F, Iughetti L. 2010. Toxic environment and obesity pandemia: is there a relationship? Ital J Pediatr 36:38.
27. Lin Y, Wei J, Li Y, Chen J, Zhou Z, Song L, et al. 2011. Developmental Exposure to Di(2-ethylhexyl) Phthalate Impairs Endocrine Pancreas and Leads to Long-term Adverse Effects on Glucose Homeostasis in the Rat. Am J Physiol Endocrinol Metab 301:E527-E538; doi:10.1152/ajpendo.00233.2011 [Online 14 June 2011].
28. Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chellakooty M, et al. 2005. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect 114:270-276.
29. Marsman D. 1995. NTP Technical Report on the Toxicity Studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Toxicity Report Series 30. Research Triangle Park, NC:National Toxicology Program.
30. Moore RW, Rudy TA, Lin TM, Ko K, Peterson RE. 2001. Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer di(2-ethylhexyl) phthalate. Environ Health Perspect 109:229-237.
31. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM 2007. The epidemiology of obesity. Gastroenterology 132: 2087-2102.
32. Pant N, Shukla M, Kumar Patel D, Shukla Y, Mathur N, Kumar Gupta Y, et al. 2008. Correlation of phthalate exposures with semen quality. Toxicol and Appl Pharmacol 231(1):112-116.
33. Pasquali R, Gambineri A. 2006. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann NY Acad Sci 1092:158-174.
34. Sargis RM, Johnson DN, Choudhury RA, Brady MJ. 2009. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 18(7):1283-1288.
35. Sharpe RM. 2006. Pathways of endocrine disruption during male sexual differentiation and masculinization. Best Pract Res Clin Endocrinol Metab 20(1):91-110.
36. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. 2007. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect 115:876-882.
37. Swan SH. 2008. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res 108(2):177-184.
38. Takai R, Hayashi S, Kiyokawa J, Iwata Y, Matsuo S, Suzuki M, et al. 2009. Collaborative work on evaluation of ovarian toxicity. 10) Two- or four-week repeated dose studies and fertility study of di-(2-ethylhexyl) phthalate (DEHP) in female rats. J Toxicologycal Science 34(suppl 1):SP111-SP119.
39. Terra X, Quintero Y, Auguet T, Porras JA, Hernández M, Sabench F, et al. 2011. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur J Endocrinol 164(4):539-547.
40. Trujillo ME, Scherer PE. 2005. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:167-175.
41. Wittassek M, Angerer J, Kolossa-Gehring M, Schäfer SD, Klockenbusch W, Dobler L, et al. 2009. Fetal exposure to phthalates-a pilot study. Int J Hyg Environ Health 212(5):492-498.
42. WHO (World Health Organization). 2000. Part I: The problem of overweight and obesity. In: Obesity: Preventing and Managing the Global Epidemic. Technical Report Series 894. Geneva:WHO, 5-37. Available: http://whqlibdoc.who.int/trs/WHO_TRS_894_(part1).pdf [accessed 21 June 2012].
43. WHO (World Health Organization). 2003. Chemical Fact Sheets: Di(2-ethylhexyl)phthalate. Available: http://www.who.int/water_sanitation_health/dwq/chemicals/di2ethylhexylphthalatesum.pdf [accessed 24 June 2012].
44. WHO (World Health Organization). 2012. Obesity: Facts and Figures. Available: http://www.euro.who.int/en/what-we-do/health-topics/noncommunicable-diseases/obesity [accessed 1 May 2012].
45. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, et al. 2006. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52(3):405-413.